However, large obesity trials did not show clinically meaningful weight loss, and regulators have raised concerns about immunogenicity and safety data gaps, which is why Better Med Spa restricts its use to clearly informed, highly selected clients
Once opened, its suitable for 28 days if you keep it clean
The compound extends that protective, regenerative capacity throughout the body particularly to tendons, ligaments, the vascular system, and the gut lining
Semaglutide delivers 14.9% body weight loss in STEP-1 (4,500+ patients)
Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760
Vitamin B12 deficiency in over 16s: diagnosis and management (NG239) Recommendations
